 Jaguar Health Inc NASDAQ: JAGX shares are trading higher by 31.2 at 0.70 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East. Per. 